Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine

Transplant Proc. 2003 Mar;35(2):678. doi: 10.1016/s0041-1345(03)00095-2.

Authors

G Sahar¹, M Berman, T Ben-Gal, E Sahar, A Kogan, R Michowitch, M Saute, M Kramer, A Sagie, Y Shapira, D Aravot, B A Vidne

Affiliation

¹ Department of Cardiothoracic Surgery, Heart-Lung Transplant Unit, Rabin Medical Center, Beilinson Campus, Israel.

PMID: 12644092
DOI: 10.1016/s0041-1345(03)00095-2

No abstract available

Publication types

Clinical Trial
Comparative Study
Controlled Clinical Trial

MeSH terms

Blood Glucose / metabolism*
Cyclosporine / blood
Cyclosporine / therapeutic use*
Follow-Up Studies
Heart Transplantation / immunology
Heart Transplantation / physiology*
Humans
Immunosuppressive Agents / blood
Immunosuppressive Agents / therapeutic use*
Tacrolimus / blood
Tacrolimus / therapeutic use*
Time Factors

Substances

Blood Glucose
Immunosuppressive Agents
Cyclosporine
Tacrolimus